loader image
Friday, December 19, 2025
68.9 F
McAllen
- Advertisement -

New Board-Certified Hematology/Oncology Physician Joins DHR Health

Translate to Spanish or other 102 languages!

DHR Health Oncology Institute Welcomes Relindis N. Azenwi Fru, M.D. to the Rio Grande Valley. DHR Health Image
DHR Health Oncology Institute Welcomes Relindis N. Azenwi Fru, M.D. to the Rio Grande Valley. DHR Health Image

Mega Doctor News

- Advertisement -

Edinburg, TX – DHR Health is excited welcome Relindis N. Azenwi Fru, M.D. to their compassionate team of hematologists and oncologists at the DHR Health Oncology Institute in Edinburg, TX. 

Prior to joining DHR Health, Dr. Azenwi Fru was a Resident Physician in the Department of Internal Medicine at The University of Texas Medical Branch – Galveston, and a Fellowship Physician of Hematology and Oncology at Roger Williams Medical Center in Providence, RI shortly after receiving a Doctor of Medicine from The Commonwealth Medical College in Scranton, PA in 2015. 

She has been board certified by the American Board of Internal Medicine since 2018, and is a member of the American College of Physicians and Texas Medical Association.

- Advertisement -

The dedicated team player is also a proud Captain in the US Army Reserve.

Dr. Azenwi Fru is credited with creating a community outreach program to promote cervical cancer awareness and provide affordable screening and immunizations in the local communities of the South West Region of Cameroon. As a member of the Cameroonian-American Foundation of Michigan, the well-rounded Dr. Azenwi Fru educated teens and adolescents of African descent on the dangers of alcohol and drug abuse.

She will play an integral part in providing extensive medical care, treatment and support to cancer patients in the Rio Grande Valley.

When she isn’t treating cancer patients and encouraging cancer awareness, Dr. Azenwi spends time cooking and dancing to African folk music with her children and husband.

- Advertisement -

For more information on the services provided at DHR Health Oncology Institute or to schedule an appointment with Dr. Relindis N. Azenwi Fru, please call (956) 362-2250 or visit our website at www.dhrhealth.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×